BioMarin’s stock falls after another company’s dwarfism drug moves into Phase 3 clinical trials

United States News News

BioMarin’s stock falls after another company’s dwarfism drug moves into Phase 3 clinical trials
United States Latest News,United States Headlines
  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 97%

Shares of BioMarin Pharmaceutical Inc. were down about 6.0% in premarket trading on Monday after BridgeBio Pharma Inc. shared positive Phase 2 clinical data...

Shares of BioMarin Pharmaceutical Inc. BMRN were down about 6.0% in premarket trading on Monday after BridgeBio Pharma Inc. BBIO shared positive Phase 2 clinical data about its experimental dwarfism drug, which could compete with BioMarin’s Voxzogo if and when it’s approved. BioMarin received Food and Drug Administration approval for Voxzogo as a treatment for some children 5 years old and older with achondroplasia in late 2021. The drug generated about $169 million in sales last year.

... Shares of BioMarin Pharmaceutical Inc. BMRN were down about 6.0% in premarket trading on Monday after BridgeBio Pharma Inc. BBIO shared positive Phase 2 clinical data about its experimental dwarfism drug, which could compete with BioMarin’s Voxzogo if and when it’s approved. BioMarin received Food and Drug Administration approval for Voxzogo as a treatment for some children 5 years old and older with achondroplasia in late 2021. The drug generated about $169 million in sales last year.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

MarketWatch /  🏆 3. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

MO Stock Price | Altria Group Inc. Stock Quote (U.S.: NYSE) | MarketWatchMO Stock Price | Altria Group Inc. Stock Quote (U.S.: NYSE) | MarketWatchMO | Complete Altria Group Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Read more »

BridgeBio’s stock rallies 50% on new data from dwarfism therapyBridgeBio’s stock rallies 50% on new data from dwarfism therapyShares of BridgeBio Pharma Inc. soared about 52% in premarket trading on Monday after the company shared positive data from a Phase 2 clinical trial about...
Read more »

MCU Phase 5 Is Already Continuing A Wonderful New Marvel TrendMCU Phase 5 Is Already Continuing A Wonderful New Marvel TrendMarvel Studios' Phase 4 doubled down on a great visual MCU trend, and thankfully, it looks like Phase 5 will be continuing and expanding on it.
Read more »

AUD/USD: Weak phase over? – UOBAUD/USD: Weak phase over? – UOBIn the opinion of UOB Group’s Economist Lee Sue Ann and Markets Strategist Quek Ser Leang, AUD/USD has now likely moved into a consolidative range. Ke
Read more »

Iran completes pre-pilot phase of central bank digital currencyIran completes pre-pilot phase of central bank digital currencyThe Central Bank of Iran plans to increase the scope of the CBDC pilot in the country’s payment system following completion of a pre-pilot phase.
Read more »

German minister says on right track with EU over combustion engine phase-outGerman minister says on right track with EU over combustion engine phase-outGermany's transport minister said on Monday that he was optimistic a row with the European Union over a bid to ban new cars with internal combustion engines could be solved, but added a decision did not need to be made in the coming days.
Read more »



Render Time: 2025-02-22 04:21:35